glp 1 in obesity The Unstoppable Rise of GLP-1 Agonists: Revolutionising Diabetes and Treatment GLP-1 Medications – Community Education

However, in individuals with type 2 diabetes, this doesnt function properly, and glucagon is overactive

[1] In phase 3 trials, orforglipron produced 12.4% weight loss (27.3 lbs) at 72 weeks less than injectable tirzepatide (20%) but comparable to oral semaglutide

Indeed, an opposite approach, as the pulse feeding strategy, whereby ~ 80% of daily protein is consumed in a single meal, has been shown to improve nitrogen retention in older women and to enhance lean mass preservation in malnourished elderly patients [47]

Moreover, the experts argued that science is at a transition point in the food system, driven by GLP-1 medications and nutrient consumption levels for optimal health